DRD4 VNTR polymorphism and age at onset of severe mental illnesses

Neuroscience Letters

Volumn 519, Issue 1, 2012, Pages 9-13

  Gonçalves, Vanessa Faria ^a,b   Tiwari, Arun K ^a,b   de Luca, Vincenzo ^a,b   Kong, Say Li ^c   Zai, Clement ^a,b   Tampakeras, Maria ^a   MacKenzie, Bronwyn ^a   Sun, Lei ^b   Kennedy, James L ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

Age at onset; Bipolar disorder; DRD4 gene; Gender; Schizophrenia

Indexed keywords

DOPAMINE 4 RECEPTOR;

ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX; VARIABLE NUMBER OF TANDEM REPEAT;

AGE DISTRIBUTION; AGE OF ONSET; BIPOLAR DISORDER; EUROPE; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RECEPTORS, DOPAMINE D4; RISK FACTORS; SCHIZOPHRENIA; TANDEM REPEAT SEQUENCES;

EID: 84861796045     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.04.027     Document Type: Article

References (48)

1. Abecasis G.R., Wigginton J.E. Handling marker-marker linkage disequilibrium: pedigree analysis with clustered markers. American Journal of Human Genetics 2005, 77(5):754-767.
2. Ambrósio A.M., Kennedy J.L., Macciardi F., Barr C., Soares M.J., Oliveira C.R., Pato C.N. No evidence of association or linkage disequilibrium between polymorphisms in the 5' upstream and coding regions of the dopamine D4 receptor gene and schizophrenia in a Portuguese population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2004, 125B:20-24.
3. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H.H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. Journal of Neurochemistry 1995, 65:1157-1165.
4. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus acumbens. Pharmacology, Biochemistry, and Behavior 1999, 64:803-812.
5. Benedetti F., Dallaspezia S., Colombo C., Pirovano A., Marino E., Smeraldi E. A length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder. Neuroscience Letters 2008, 445:184-187.
6. Carter T.D., Mundo E., Parikh S.V., Kennedy J.L. Early age at onset as a risk factor for poor outcome of bipolar disorder. Journal of Psychiatric Research 2003, 37:297-303.
7. Cerullo M.A., Strakowski S.M. The prevalence and significance of substance use disorders in bipolar type I and II disorder. Substance Abuse Treatment, Prevention, and Policy 2007, 2:29.
8. Cho J.J., Iannucci F.A., Fraile M., Franco J., Alesius T.N., Stefano G.B. The role of the estrogen in neuroprotection: implications for neurodegenerative diseases. Neuro Endocrinology Letters 2003, 24:141-147.
9. Ding Y.C., Chi H.C., Grady D.L., Morishima A., Kidd J.R., Kidd K.K., Flodman P., Spence M.A., Schuck S., Swanson J.M., Zhang Y.P., Moyzis R.K. Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:309-314.
10. Dmitrieva J., Chen C., Greenberger E., Ogunseitan O., Ding Y.C. Gender-specific expression of the DRD4 gene on adolescent delinquency, anger and thrill seeking. Social Cognitive and Affective Neuroscience 2011, 6:82-89.
11. Dmitrzak-Weglarz M., Rybakowski J.K., Slopien A., Czerski P.M., Leszczynska-Rodziewicz A., Kapelski P., Kaczmarkiewicz-Fass M., Hauser J. Dopamine receptor D1 gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology 2006, 53:46-50.
12. Faraone S.V., Doyle A.E., Mick E., Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. American Journal of Psychiatry 2001, 158:1052-1057.
13. Glatt S.J., Faraone S.V., Tsuang M.T. Schizophrenia is not associated with DRD4 48-base-pair-repeat length or individual alleles: results of a meta-analysis. Biological Psychiatry 2003, 54:629-635.
14. Heffner J.L., DelBello M.P., Fleck D.E., Anthenelli R.M., Strakowski S.M. Cigarette smoking in the early course of bipolar disorder: association with ages-at-onset of alcohol and marijuana use. Bipolar Disorders 2008, 10:838-845.
15. Huang J., Perlis R.H., Lee P.H., Rush A.J., Fava M., Sachs G.S., Lieberman J., Hamilton S.P., Sullivan P., Sklar P., Purcell S., Smoller J.W. Cross-disorder genome wide analysis of schizophrenia bipolar disorder, and depression. American Journal of Psychiatry 2010, 167:1254-1263.
16. Hwang R., Tiwari A.K., Zai C.C., Felsky D., Remington E., Wallace T., Tong R.P., Souza R.P., Oh G., Potkin S.G., Lieberman J.A., Meltzer H.Y., Kennedy J.L. Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012, 37:62-75.
17. Jönsson E., Brené S., Geijer T., Terenius L., Tylec A., Persson M.L., Sedvall G. A search for association between schizophrenia and dopamine-related alleles. European Archives of Psychiatry and Clinical Neuroscience 1996, 246:297-304.
18. Jovanovic V., Guan H.C., Van Tol H.H. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics 1999, 9:561-568.
19. Kaiser R., Könneker M., Henneken M., Dettling M., Müller-Oerlinghausen B., Roots I., Brockmöller J. Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment but association with catatonic schizophrenia. Molecular Psychiatry 2000, 5:418-424.
20. LaHoste G.J., Swanson J.M., Wigal S.B., Glabe C., Wigal T., King N., Kennedy J.L. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiatry 1996, 1:121-124.
21. Lahiri D.K., Nurnberger Jr. J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research 1991, 19:5444.
22. Lee S.H., Mouradian M.M. Up-regulation of D1A dopamine receptor gene transcription by estrogen. Molecular and Cellular Endocrinology 1999, 156:151-157.
23. Lichter J.B., Barr C.L., Kennedy J.L., Van Tol H.H., Kidd K.K., Livak K.J. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Human Molecular Genetics 1993, 2:767-773.
24. Kong S.L., Li G., Loh S.L., Sung W.K., Liu E.T. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state. Molecular Systems Biology 2011, 7:526.
25. Lagerberg T.V., Andreassen O.A., Ringen P.A., Berg A.O., Larsson S., Agartz I., Sundet K., Melle I. Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study. BMC Psychiatry 2010, 10:9.
26. Lim L.C., Nöthen M.M., Körner J., Rietschel M., Castle D., Hunt N., Propping P., Murray R., Gill M. No evidence of association between dopamine D4 receptor variants and bipolar affective disorder. American Journal of Medical Genetics 1994, 54:259-263.
27. López León S., Croes E.A., Sayed-Tabatabaei F.A., Claes S., Van Broeckhoven C., van Duijn C.M. The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis. Biological Psychiatry 2005, 57:999-1003.
28. Lung F.W., Shu B.C., Kao W.T., Chen C.N., Ku Y.C., Tzeng D.S. Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study. BMC Medical Genetics 2009, 10:147.
29. Lung F.W., Yang M.C., Shu B.C. The interleukin 10 promoter haplotype ACA and the long-form variant of the DRD4 uVNTR polymorphism are associated with vulnerability to schizophrenia. Psychiatry Research 2011, 188:294-296.
30. Massat I., Kocabas N.A., Crisafulli C., Chiesa A., Calati R., Linotte S., Kasper S., Fink M., Antonijevic I., Forray C., Snyder L., Bollen J., Zohar J., De Ronchi D., Souery D., Serretti A., Mendlewicz J. COMT age at onset in mood disorders: a replication and extension study. Neuroscience Letters 2011, 498:218-221.
31. McCarthy M.M., Arnold A.P., Ball G.F., Blaustein J.D., De Vries G.L. Sex differences in the brain: the not so inconvenient truth. The Journal of Neuroscience 2012, 32:2241-2247.
32. McNamara R.K., Nandagopal J.J., Strakowski S.M., DelBello M.P. Preventative strategies for early-onset bipolar disorder: towards a clinical staging model. CNS Drugs 2010, 24:983-996.
33. Mendrek A., Stip E. Sexual dimorphism in schizophrenia: is there a need for gender-based protocols?. Expert Review of Neurotherapeutics 2011, 11:951-959.
34. Muglia P., Petronis A., Mundo E., Lander S., Cate T., Kennedy J.L. Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4. Molecular Psychiatry 2002, 7:860-866.
35. Nicolini H., Arnold P., Nestadt G., Lanzagorta N., Kennedy J.L. Overview of genetics and obsessive-compulsive disorder. Psychiatry Research 2009, 170:7-14.
36. Nikolaidis A., Gray J.R. ADHD and the DRD4 exon III 7-repeat polymorphism: an international meta-analysis. Social Cognitive and Affective Neuroscience 2010, 5:188-193.
37. Numata S., Ueno S., Iga J., Yamauchi K., Hongwei S., Ohta K., Kinouchi S., Shibuya-Tayoshi S., Tayoshi S., Aono M., Kameoka N., Sumitani S., Tomotake M., Kaneda Y., Taniguchi T., Ishimoto Y., Ohmori T. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neuroscience Letters 2006, 401:1-5.
38. Petronis A., Macciardi F., Athanassiades A., Paterson A.D., Verga M., Meltzer H.Y., Cola P., Buchanan J.A., Van Tol H.H., Kennedy J.L. Association study between the dopamine D4 receptor gene and schizophrenia. American Journal of Medical Genetics 1995, 60:452-455.
39. Renou J., De Luca V., Zai C.C., Bulgin N., Remington G., Meltzer H.Y., Lieberman J.A., Le Foll B., Kennedy J.L. Multiple variants of the DRD3 but not BDNF gene, influence age-at-onset of schizophrenia. Molecular Psychiatry 2007, 12:1058-1060.
40. Sanak M., Zelek-Molik A., Nalepa I., Wegrzyn J., Wciorka J. The dopamine D4 receptor VNTR in Polish schizophrenia patients. Schizophrenia Research 2005, 73:129-131.
41. Savitz J., van der Merwe L., Solms M., Ramesar R. A linkage and family-based association analysis of a potential neurocognitive endophenotype of bipolar disorder. Neuromolecular Medicine 2007, 9:101-116.
42. Seeman P., Van Tol H.H. Dopamine receptor pharmacology. Trends in Pharmacological Sciences 1994, 15:264-270.
43. Segman R.H., Goltser T., Heresco-Levy U., Finkel B., Shalem R., Schlafman M., Yakir A., Greenberg D., Strous R., Lerner A., Shelevoy A., Lerer B. Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia. The Pharmacogenomics Journal 2003, 3:277-283.
44. Serretti A., Lorenzi C., Mandelli L., Cichon S., Schumacher J., Nöthen M.M., Rietschel M., Tullius M., Ohlraun S. DRD4 exon 3 variants are not associated with symptomatology of major psychoses in a German population. Neuroscience Letters 2004, 368:269-273.
45. Singh M.K., DelBello M.P., Kowatch R.A., Strakowski S.M. Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children. Bipolar Disorders 2006, 8:710-720.
46. Squassina A., Manchia M., Costa M., Chillotti C., Ardau R., Del Zompo M., Severino G. Age at onset in bipolar disorder: investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample. European Psychiatry 2011, 26:141-143.
47. Swartz M.S., Wagner H.R., Swanson J.W., Stroup T.S., McEvoy J.P., Canive J.M., Miller D.D., Reimherr F., McGee M., Khan A., Van Dorn R., Rosenheck R.A., Lieberman J.A. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. Journal of Nervous and Mental Disease 2006, 194:164-172.
48. Van Tol H.H., Wu C.M., Guan H.C., Ohara K., Bunzow J.R., Civelli O., Kennedy J., Seeman P., Niznik H.B., Jovanovic V. Multiple dopamine D4 receptor variants in the human population. Nature 1992, 358:149-152.